Skip to content

Acurx Pharmaceuticals, Inc.: filings

Every Acurx Pharmaceuticals, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 21 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-13fiscal Q2 202621680001104659-26-095904
10-Q2026-05-11fiscal Q1 202621460001104659-26-058631
10-K2026-03-12fiscal FY 202521440001104659-26-027052
10-Q2025-11-12fiscal Q3 202521720001104659-25-109698
10-Q2025-08-11fiscal Q2 202521680001558370-25-011045
10-Q2025-05-12fiscal Q1 202520440001558370-25-007371
10-K2025-03-17fiscal FY 202420420001558370-25-003117
10-Q2024-11-12fiscal Q3 202420680001558370-24-015310
10-Q2024-08-08fiscal Q2 202420640001558370-24-011587
10-Q2024-05-14fiscal Q1 202420430001558370-24-008130
10-K2024-03-15fiscal FY 202320420001558370-24-003401
10-Q2023-11-13fiscal Q3 202320680001558370-23-018824
10-Q2023-08-11fiscal Q2 202321640001558370-23-014645
10-Q2023-05-12fiscal Q1 202319420001558370-23-009495
10-K2023-03-15fiscal FY 202222440001558370-23-003929
10-Q2022-11-10fiscal Q3 202222700001558370-22-017408
10-Q2022-08-12fiscal Q2 202222620001410578-22-002396
10-Q2022-05-10fiscal Q1 202220400001410578-22-001250
10-K2022-03-16fiscal FY 202121390001410578-22-000399
10-Q2021-11-12fiscal Q3 202121600001104659-21-138038
10-Q2021-08-13fiscal Q2 202116410001104659-21-105074

Inspect the source

Entity
Acurx Pharmaceuticals, Inc. / CIK 0001736243
Captured
2026-09-21T17:25:29.911Z
SEC response SHA-256
3ff72a27b12e3bbf2238c568e6d540d3ffd8acf36c9060b3da0911bb5446b5e9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001736243.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))